Active, not recruitingPhase 1NCT04477200

Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma

Studying Glioblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Michigan Rogel Cancer Center
Principal Investigator
Nathan Clarke, MD
University of Michigan Rogel Cancer Center
Intervention
Mycophenolate Mofetil(drug)
Enrollment
68 enrolled
Eligibility
18 years · All sexes
Timeline
2020 – 2027

Study locations (1)

Collaborators

National Cancer Institute (NCI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04477200 on ClinicalTrials.gov

Other trials for Glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Glioblastoma →

← Back to all trials